The company currently supplies one product to the US market that contributes low- single digit revenue to Jubilant Pharmova revenue
The company has received the Certificate of GMP Compliance from the representative European inspection authority, Health Products Regulatory Authority (HPRA), Ireland.
The newest facility has all the core specialties like Obstetrics and Gynaecology, Orthopaedics, Neurology, Cardiology, Paediatrics, General Surgery, and Urology
The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
None of the observations are related to data integrity and Alembic Pharmaceuticals management believes that they are addressable
The training center will focus on providing radiation oncologists, radiotherapy technologists, and medical physicists with the necessary skills
The certification will open new avenues for our flagship brand “Dr Trust”, enabling them to export these devices to many more countries
This win is on the back of a prestigious order from Reliance Life Sciences
Construction is now underway with the facility scheduled to be operational by 2025
The inspection of the facility was conducted from August 16-19, 2022.
Subscribe To Our Newsletter & Stay Updated
